NCT07318701Not yet recruiting
Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy
Multi-agent Large Language Models for Multidisciplinary Decision Support in Cervical Cancer During Pregnancy
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
The aim of this study is to develop an AI-assisted decision-making system based on multi-agent large language models and to evaluate its effectiveness and accuracy in the diagnosis and treatment of cervical cancer during pregnancy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 18 Dec 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Obstetrics & Gynecology Hospital of Fudan University
- Diseases
- Cervical cancer, Childhood cancers
- NCT number
- NCT07318701
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 1 Jan 2026 to the primary completion date, 30 Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women with cervical cancer confirmed by tissue testing, who are about to start their first treatment.
- Sex
- Female only.
- Disease stage
- Cervical cancer confirmed by pathology (tissue examination), during pregnancy.
- Earlier treatment
- Must be receiving initial treatment. Anyone already treated for cervical cancer during this pregnancy cannot join.
- Biomarker or test result
- Ultrasound must confirm a pregnancy inside the uterus.
Main reasons for not taking part
- Previous treatment for cervical cancer during pregnancy
- Abnormal pregnancy, for example ectopic pregnancy
- Cannot or will not sign informed consent
This trial only enrols pregnant participants. The registry sentence this rests on: Confirmed intrauterine pregnancy status via ultrasound.
Read by machine on 9 Nov 2026.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous treatment received for cervical cancer during pregnancy.
Other
- Pathological pregnancy states (e.g., ectopic pregnancy).
- Inability or unwillingness to provide signed informed consent.
Who the study is looking for
- Pathologically confirmed diagnosis of cervical cancer.
- Confirmed intrauterine pregnancy status via ultrasound.
- Patients receiving initial treatment.
- Agreement to participate in the study with signed informed consent.
Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.